|
1
|
Gatta G, Botta L, Rossi S, Aareleid T,
Bielska-Lasota M, Clavel J, Dimitrova N, Jakab Z, Kaatsch P, Lacour
B, et al EUROCARE Working Group: Childhood cancer survival in
Europe 1999–2007: Results of EUROCARE-5 - a population-based study.
Lancet Oncol. 15:35–47. 2014. View Article : Google Scholar
|
|
2
|
Landskron G, De la Fuente M, Thuwajit P,
Thuwajit C and Hermoso MA: Chronic inflammation and cytokines in
the tumor microenvironment. J Immunol Res. 2014:1491852014.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen GY and Nuñez G: Sterile inflammation:
Sensing and reacting to damage. Nat Rev Immunol. 10:826–837. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yang Q, Shi Y, Yang Y, Lou G and Chen Z:
The sterile inflammation in the exacerbation of HBV-associated
liver injury. Mediators Inflamm. 2015:5086812015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Demaria S, Pikarsky E, Karin M, Coussens
LM, Chen YC, El-Omar EM, Trinchieri G, Dubinett SM, Mao JT, Szabo
E, et al: Cancer and inflammation: Promise for biologic therapy. J
Immunother. 33:335–351. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Agyeman P, Kontny U, Nadal D, Leibundgut
K, Niggli F, Simon A, Kronenberg A, Frei R, Escobar H, Kühne T, et
al: A prospective multicenter study of microbiologically defined
infections in pediatric cancer patients with fever and neutropenia:
Swiss Pediatric Oncology Group 2003 fever and neutropenia study.
Pediatr Infect Dis J. 33:e219–e225. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Khurana M, Lee B and Feusner JH: Fever at
diagnosis of pediatric acute lymphoblastic leukemia: Are
antibiotics really necessary? J Pediatr Hematol Oncol. 37:498–501.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Santolaya ME, Alvarez AM, Becker A, Cofré
J, Enríquez N, O'Ryan M, Payá E, Pilorget J, Salgado C, Tordecilla
J, et al: Prospective, multicenter evaluation of risk factors
associated with invasive bacterial infection in children with
cancer, neutropenia, and fever. J Clin Oncol. 19:3415–3421.
2001.PubMed/NCBI
|
|
9
|
Santolaya ME, Farfán MJ, De La Maza V,
Cociña M, Santelices F, Alvarez AM, Avilés CL, Becker A, O'Ryan M,
Román P, et al: Diagnosis of bacteremia in febrile neutropenic
episodes in children with cancer: Microbiologic and molecular
approach. Pediatr Infect Dis J. 30:957–961. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Barrera L, Montes-Servín E, Barrera A,
Ramírez-Tirado LA, Salinas-Parra F, Bañales-Méndez JL,
Sandoval-Ríos M and Arrieta Ó: Cytokine profile determined by
data-mining analysis set into clusters of non-small-cell lung
cancer patients according to prognosis. Ann Oncol. 26:428–435.
2015. View Article : Google Scholar
|
|
11
|
Mojtahedi Z, Khademi B, Erfani N, Taregh
Y, Rafati Z, Malekzadeh M and Ghaderi A: Serum levels of
interleukin-7 and interleukin-8 in head and neck squamous cell
carcinoma. Indian J Cancer. 51:227–230. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sato T, Terai M, Tamura Y, Alexeev V,
Mastrangelo MJ and Selvan SR: Interleukin 10 in the tumor
microenvironment: A target for anticancer immunotherapy. Immunol
Res. 51:170–182. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Buyukberber N, Buyukberber S, Sevinc A and
Camci C: Cytokine concentrations are not predictive of bacteremia
in febrile neutropenic patients. Med Oncol. 26:55–61. 2009.
View Article : Google Scholar
|
|
14
|
Fleischhack G, Cipic D, Juettner J, Hasan
C and Bode U: Procalcitonin-a sensitive inflammation marker of
febrile episodes in neutropenic children with cancer. Intensive
Care Med. 26(Suppl 2): S202–S211. 2000.
|
|
15
|
Castellheim A, Brekke OL, Espevik T,
Harboe M and Mollnes TE: Innate immune responses to danger signals
in systemic inflammatory response syndrome and sepsis. Scand J
Immunol. 69:479–491. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dinarello CA: Interleukin-1, interleukin-1
receptors and interleukin-1 receptor antagonist. Int Rev Immunol.
16:457–499. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Horacek JM, Kupsa T, Vasatova M, Jebavy L
and Zak P: Evaluation of serum levels of multiple cytokines and
adhesion molecules in patients with newly diagnosed acute
lymphoblastic leukemia using biochip array technology. Exp Oncol.
35:229–230. 2013.PubMed/NCBI
|
|
18
|
Zhao C, Chen A, Jamieson CH, Fereshteh M,
Abrahamsson A, Blum J, Kwon HY, Kim J, Chute JP, Rizzieri D, et al:
Hedgehog signalling is essential for maintenance of cancer stem
cells in myeloid leukaemia. Nature. 458:776–779. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Su YC, Li SC, Wu YC, Wang LM, Chao KS and
Liao HF: Resveratrol downregulates interleukin-6-stimulated sonic
hedgehog signaling in human acute myeloid leukemia. Evid Based
Complement Alternat Med. 2013:5474302013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Abrahamsson J, Påhlman M and Mellander L:
Interleukin 6, but not tumour necrosis factor-alpha, is a good
predictor of severe infection in febrile neutropenic and
non-neutropenic children with malignancy. Acta Paediatr.
86:1059–1064. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Diepold M, Noellke P, Duffner U, Kontny U
and Berner R: Performance of interleukin-6 and interleukin-8 serum
levels in pediatric oncology patients with neutropenia and fever
for the assessment of low-risk. BMC Infect Dis. 8:282008.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wu W, Jia Y, Du S, Tang H, Sun Y and Sun
L: Changes of sulfur dioxide, nuclear factor-κB, and interleukin-8
levels in pediatric acute lymphoblastic leukemia with bacterial
inflammation. Chin Med J (Engl). 127:4110–4113. 2014.
|
|
23
|
Civini S, Jin P, Ren J, Sabatino M,
Castiello L, Jin J, Wang H, Zhao Y, Marincola F and Stroncek D:
Leukemia cells induce changes in human bone marrow stromal cells. J
Transl Med. 11:2982013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Eisenkraft A, Keidan I, Bielorai B, Keller
N, Toren A and Paret G: MCP-1 in the cerebrospinal fluid of
children with acute lymphoblastic leukemia. Leuk Res. 30:1259–1261.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bertolizio G, Stucchi R, Sahillioglu E,
Somaini M, Dander E, Biondi A, Jankovic M, D'Amico G and Ingelmo
PM: The effects of propofol and ketamine on the cytokine levels of
children with acute lymphoblastic leukemia. J Pediatr Hematol
Oncol. 35:e296–e300. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Du S, Jia Y, Tang H, Sun Y, Wu W, Sun L,
Du J, Geng B, Tang C and Jin H: Immune regulation of hydrogen
sulfide in children with acute lymphoblastic leukemia. Chin Med J
(Engl). 127:3695–3699. 2014.
|
|
27
|
Hatzistilianou M, Rekliti A, Athanassiadou
F and Catriu D: Procalcitonin as an early marker of bacterial
infection in neutropenic febrile children with acute lymphoblastic
leukemia. Inflamm Res. 59:339–347. 2010. View Article : Google Scholar
|
|
28
|
Matti BF, Saleem MA and Sabir SF:
Assessment of interleukin 1β serum level in different responder
groups and stages of chronic myeloid leukemia patients on imatinb
mesylate therapy. Indian J Hematol Blood Transfus. 30:247–252.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang S, Sun M, Gu C, Wang X, Chen D, Zhao
E, Jiao X and Zheng J: Expression of CD163, interleukin-10, and
interferon-gamma in oral squamous cell carcinoma: Mutual
relationships and prognostic implications. Eur J Oral Sci.
122:202–209. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Weaver CT, Hatton RD, Mangan PR and
Harrington LE: IL-17 family cytokines and the expanding diversity
of effector T cell lineages. Annu Rev Immunol. 25:821–852. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Weaver CT: Th17: The ascent of a new
effector T-cell subset. Preface Eur J Immunol. 39:634–636. 2009.
View Article : Google Scholar
|
|
32
|
Kolls JK and Lindén A: Interleukin-17
family members and inflammation. Immunity. 21:467–476. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Han Y, Ye A, Bi L, Wu J, Yu K and Zhang S:
Th17 cells and interleukin-17 increase with poor prognosis in
patients with acute myeloid leukemia. Cancer Sci. 105:933–942.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zitvogel L and Kroemer G:
CD103+ dendritic cells producing interleukin-12 in
anticancer immunosurveillance. Cancer Cell. 26:591–593. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lehmann D, Spanholtz J, Osl M, Tordoir M,
Lipnik K, Bilban M, Schlechta B, Dolstra H and Hofer E: Ex vivo
generated natural killer cells acquire typical natural killer
receptors and display a cytotoxic gene expression profile similar
to peripheral blood natural killer cells. Stem Cells Dev.
21:2926–2938. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Pegram HJ, Purdon TJ, van Leeuwen DG,
Curran KJ, Giralt SA, Barker JN and Brentjens RJ: IL-12-secreting
CD19-targeted cord blood-derived T cells for the immunotherapy of
B-cell acute lymphoblastic leukemia. Leukemia. 29:415–422. 2015.
View Article : Google Scholar
|
